Charles River Laboratories International (NYSE:CRL) Lifted to Buy at StockNews.com

StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a report issued on Thursday morning. Several other equities analysts also recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Charles River Laboratories International from $270.00 to $280.00 […]

Leave a Reply

Your email address will not be published.

Previous post Core & Main (NYSE:CNM) Price Target Cut to $50.00 by Analysts at Truist Financial
Next post Stephens Reaffirms “Overweight” Rating for Encompass Health (NYSE:EHC)